- Controversies in borderline ovarian tumors
-
Seong SJ, Kim DH, Kim MK, Song T
- KMID: 2345926
- J Gynecol Oncol.
- 2015 Oct;26(4):343-349.
- doi: 10.3802/jgo.2015.26.4.343
Borderline ovarian tumors (BOTs) represent about 15% to 20% of all ovarian malignancies and differ from invasive ovarian cancers (IOCs) by many characters. Historically, standard management of BOT is peritoneal... -
- CITED
-
- Close
- SHARE
-
- Close
